Drug utilisation 90% profiles - A useful tool for quality assessment of prescribing in primary health care in Stockholm

Pharmacoepidemiology and Drug Safety

Volumn 12, Issue 6, 2003, Pages 499-510

  Wettermark, Björn ^a,b   Pehrsson, Åke ^c   Jinnerot, Dane ^c   Bergman, Ulf ^a,b,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Network for Pharmacoepidemiology Foundation   (Sweden)

^c Drugs and Therapeutics Committee   (Sweden)

Author keywords

Drug utilisation; Prescribing indicators; Prescription feedback; Primary health care; Quality of prescribing

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE BESYLATE; AMOXICILLIN PLUS CLAVULANIC ACID; ATENOLOL; ATORVASTATIN; BUDESONIDE; CITALOPRAM; COCILLANA ETYFIN; ENALAPRIL MALEATE; FELODIPINE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FUROSEMIDE; LEVOTHYROXINE SODIUM; LOSEC MUPS; METOPROLOL TARTRATE; OMEPRAZOLE; OPIATE; PENICILLIN V POTASSIUM; SERETIDE DISKUS; SERTRALINE; SILDENAFIL; SIMVASTATIN; SUMATRIPTAN SUCCINATE; TETRAHYDROLIPSTATIN; TROMBYL;

ARTICLE; DATA ANALYSIS; DRUG COST; DRUG UTILIZATION; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; SWEDEN;

AGE FACTORS; ATTITUDE OF HEALTH PERSONNEL; COMMUNITY HEALTH CENTERS; DRUG UTILIZATION REVIEW; GUIDELINE ADHERENCE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PRACTICE GUIDELINES; PRESCRIPTIONS, DRUG; QUALITY ASSURANCE, HEALTH CARE; SWEDEN;

EID: 0042914789     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.852     Document Type: Article

References (40)

1. Steffen GE. Quality medical care: a definition. JAMA 1988; 260: 56-61.
2. Haaijer-Ruskamp F. Measuring the effect of interventions to promote rational prescribing. In Eurodurg Meeting 2001: Integrating Drug Utilisation Studies in Wider Europe, Vlcek J (ed.). Galén: Prague, Czech Republic, 2001.
3. Pont LG. Assessing the quality of prescribing in general practice. Dissertation. University of Groningen, The Netherlands, 2002.
4. Holden J, Wilson R. The quality of prescribing in general practice. Int J Health Care Qual Assur 1996; 9(5): 17-23.
5. Bradley CP. Decision making and prescribing patterns-a literature review. Fam Pract 1991; 8(3): 276-287.
6. de Vries CS, Tromp TF, Blijleven W, de Jong-van den Berg LT. Prescription data as a tool in pharmacotherapy audit (I): general considerations. Pharm World Sci 1999; 21(2): 80.
7. Fish CA, Kirking DM, Martin JB. Information systems for evaluating the quality of prescribing. Ann Pharmacother 1992; 26(3): 392-398.
8. McGavock H (ed.). Handbook of Drug Use Research Methodology (1st edn). The United Kingdom Drug Utilisation Research Group: Newcastle upon Tyne, 2000.
9. Soumerai SB, Majumdar S, Lipton HL. Evaluating and improving physician prescribing. In Pharmacoepidemiology, (3rd edn), Strom BL (ed.). John Wiley:, Chichester, UK, 2000; 483-503.
10. Tomson Y, Wessling A, Tomson G. General practitioners for rational use of drugs: examples from Sweden. Eur J Clin Pharmacol 1994; 47: 213-219.
11. Bergman U, Popa C, Tomson Y, et al. Drug utilization 90%-a simple method for assessing the quality of drug prescribing. Eur J Clin Pharmacol 1998; 54: 113-118.
12. Bergman U, Andersson D, Friberg A, et al. Kvalitetsutveckling: Kvalitetsindikatorer för läkemedelsförskrivning och-hantering. Svenska Läkarsällskapet och Spri; (Quality indicators for drug use and drug handling. Issued by the Swedish Society of Medicine and the Swedish Medical Association). Svensk Medicin Nr 66, 1999.
13. Bergman U, Wettermark B. Setting up and using the DU90%-technique - a simple indicator for assessing the quality of drug prescribing. In Handbook of Drug Use Research Methodology, (1st edn), McGavock H (ed.). The United Kingdom Drug Utilisation Research Group: Newcastle upon Tyne, 2000; 155-163.
14. Lee D, Bergman U. Studies of drug utilization. In Pharmacoepidemiology, (3rd edn). Strom BL (ed.). John Wiley: Chichester, UK, 2000; 463-481.
15. Guidelines for ATC classification and DDD assignment. WHO Collaborating Centre for Drug Statistics Methodology: Oslo, 2000.
16. Rönning M, Salvesen Blix H, Harbo BT, Strom H. Different versions of the anatomical therapeutic chemical classification system and the defined daily dose-are drug utilisation data comparable? Eur J Clin Pharmacol 2000; 56: 723-727.
17. Wyatt TD, Reilly PM, Morrow NC. Short-lived effects of a formulary on anti-infective prescribing-the need for continuing peer review? Family Pract 1992; 9: 461-465.
18. Soumerai SB, McLaughlin TJ, Avorn J. Improving drug prescribing in primary care: a critical analysis of the experimental litterature. Millbank Q 1989; 67: 268-317.
19. Balas EA, Boren SA, Brown GD, Ewigman BG, Mitchell JA, Perkoff GT. Effect of physician profiling on utilization: meta-analysis of randomized clinical trials. J Gen Intern Med 1996; 11: 584-590.
20. Wensing M, Grol R. Single and combined strategies for implementing changes in primary care: a literature review. Int J Qual Health Care 1994; 6(2): 115-132.
21. Thomson O'Brian MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Audit and feedback: effects on professional practice and health care outcomes (Cochrane review). In The Cochrane Library, (Issue 4). Update Software: Oxford, 2001.
22. Zwar N, Wolk J, Gordon J, Sanson-Fisher R, Kehoe L. Influencing antibiotic prescribing in general practice: a trial of prescriber feedback and management guidelines. Fam Pract 1999; 16(5): 495-500.
23. Rokstad K, Straand J, Fugelli P. Can drug treatment be improved by feedback on prescribing profiles combined with therapeutic recommendations? A prospective, controlled trial in general practice. Clin Epidemiol 1995; 48(8): 1061-1068.
24. Ferguson RI, Salmond CE, Maling TJ. The Nelson Prescribing Project: a programmed intervention in general practice in New Zealand. Pharmacoeconomics 1995; 7(6): 555-561.
25. Stålsby-Lundborg C, Wahlström R, Oke T, Tomson G, Diwan VK. Influencing prescribing for urinary tract infection and asthma in primary care in Sweden: a randomized controlled trial of an interactive educational intervention. J Clin Epidemiol 1999; 52(8): 801-812.
26. Nilsson G, Hjemdahl P, Hässler A, Vitols S, Wallén NH, Krakau I. Feedback on prescribing rate combined with problem-oriented pharmacotherapy education as a model to improve prescribing behaviour among general practitioners. Eur J Clin Pharmacol 2001; 56: 843-848.
27. Ferber L, Bausch J, Köster I, Schubert I, Ihle P. Pharmacotherapeutic circles: results of an 18-month peer-review prescribing-improvement programme for general practitioners. Pharmacoeconomics 1999; 16(3): 273-283.
28. O'Connell DL, Henry D, Tomlins R. Randomised controlled trial of effect of feedback on general practitioners' prescribing in Australia. Br Med J; 318: 507-511.
29. McCarthy M, Wilson-Davis K, McGavock H. Relationship between the number of partners in a general practice and the number of different drugs prescribed by that practice. Br J Gen Pract 1992; 42(354): 10-12.
30. Bjerrum L, Bergman U. Wide variation in the number of different drugs prescribed by general practitioners: a prescription database study. Scand J Prim Health Care 2000; 18: 94-98.
31. Avery AJ, Heron T, Lloyd D, Harris CM, Roberts D. Investigating relationships between a range of potential indicators of general practice prescribing: an observational study. J Clin Pharm Ther 1998; 23(6): 441-450.
32. Soumerai SB, Ross-Degnan D, Fortess EE, et al. A critical analysis of studies of state drug reimbursement policies: research in need of discipline. Millbank Q 1993; 71: 217-252.
33. Ryan M, Yule B. The way of economic prescribing. Health Policy 1993; 25: 25-38.
34. Taylor RJ, Bond CM. Change in the established prescribing habits of general practitioners: an analysis of initial prescriptions in general practice. Br J Gen Pract 1991; 41: 244-248.
35. Feely J, Chan R, McManus J, O'Shea B. The influence of hospital-based prescribers on prescribing in general practice. Pharmacoeconomics 1999; 16(2): 175-181.
36. de Vries CS, van Diepen NM, Tromp TFJ, de Jong-van Berg LTW. Auditing GP's prescribing habits: cardiovascular prescribing frequently continues medication initiated by specialists. Eur J Clin Pharmacol 1996; 50: 349-352.
37. Robertson J, Fryer LF, O'Connell DL, Smith JS, Henry DA. Personal formularies: an index of prescribing quality? Eur J Clin Pharmacol 2001; 57: 333-341.
38. Nyman K, Bergens A, Björin AS, et al. Giving feedback on prescribing at a primary health care centre-important element in quality control of drug prescribing. Läkartidningen 2001; 98: 160-164, (In Swedish).
39. Chinburapa V, Larson LN, Brucks M, Draugalis J, Botman JL, Puto CP. Physician prescribing decisions: the effects of situational involvement and task complexity on information acquisition and decision making. Soc Sci Med 1993; 36: 1473-1482.
40. Sjöqvist F. Drug utilization. Proceedings Sixth International Congress of Pharmacology, Finnish Pharmacological Society, Vol 5, Clinical Pharmacology, p 39, Tuomisto J, Paasonen MK, (eds). 1975.